Kestra Medical Technologies, Ltd.（KMTS）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · KMTS · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-04	2024-04	2023-04	2021-04	2020-04
Revenue
Revenue	$59.81M	$27.81M	$7.63M	$0.00M	$0.00M
Cost of Revenue	$35.60M	$27.45M	$18.28M	$0.00M	$0.00M
Gross Profit	$24.21M	$0.36M	($10.65M)	$0.00M	$0.00M
Gross Margin %(computed)	40.47%	1.30%	-139.59%	—	—
Operating Expenses
R&D Expenses	$15.65M	$15.49M	$15.76M	$18.81M	$22.80M
G&A Expenses	$0.00M	$29.25M	$19.09M	$0.00M	$0.00M
Total Operating Expenses	$130.59M	$85.42M	$69.77M	$32.71M	$29.32M
Operating Income	($106.38M)	($85.06M)	($80.42M)	($32.71M)	($29.32M)
Operating Margin %(computed)	-177.85%	-305.83%	—	—	—
Interest Income	$3.20M	$0.00M	$0.00M	$0.00M	$0.00M
Interest Expense	$7.73M	$6.23M	$5.63M	$1.17M	$0.00M
Income Before Tax	($113.68M)	($94.10M)	($84.22M)	($33.91M)	($29.32M)
Income Tax Expense	$0.14M	$0.02M	$0.01M	$0.19M	$0.15M
Net Income	($113.81M)	($94.12M)	($84.24M)	($34.10M)	($29.47M)
Net Margin %(computed)	-190.28%	-338.39%	—	—	—
Per Share & EBITDA
EPS (Basic)	$-5.13	$-2.04	$-1.75	$-0.69	$-0.59
Wtd Avg Shares	49.53M	49.53M	49.53M	49.53M	49.53M
EBITDA	($97.98M)	($76.31M)	($73.74M)	($32.33M)	($28.84M)
EBITDA Margin %(computed)	-163.80%	-274.34%	-966.44%	—	—